Chemidarou Industrial Company
Chemidarou Industrial Company is a Tehran-based pharmaceutical manufacturer listed on the Tehran Stock Exchange under ticker دکیمی (DKIMI). Founded in 1965, it produces tablets, capsules, injectable ampoules, drops and oral suspensions across gastrointestinal, diabetes, anti-inflammatory, antibiotic and other therapeutic categories. It is relevant to buyers, suppliers and investors tracking Iran’s finished-dose medicine supply chain.
Operations & footprint
Products and services
Chemidarou Industrial Company manufactures pharmaceutical products in forms including ampoules, tablets, capsules, drops, suspensions, and supplements. Its therapeutic coverage includes painkillers, cardiovascular, anti-diabetic, anti-fungal, digestive, antibiotic, antihistamine, rheumatology, anti-gout, urology, neuropsychiatric, and food-supplement categories.
Operations and assets
The Tehran operation manufactures simple and coated tablets, injectable ampoules, capsules, drops and oral suspensions for multiple therapeutic uses.
Geographic footprint
Tehran, Iran.
Commercial and investment relevance
Chemidarou is relevant for investors assessing Iran's listed pharmaceutical sector, domestic drug production, therapeutic diversification, import dependence for APIs and excipients, and pricing regulation. It can support analysis of medicine shortages, production resilience, distributor payment cycles, regulatory reimbursement, and the ability of local manufacturers to substitute imported finished drugs. Due diligence should review current financial disclosures, product registrations, GMP status, raw-material sourcing, export channels, energy and packaging costs, receivables, and shareholder or holding-company relationships. Chemidarou is a potential manufacturing and supply-chain counterpart for buyers and distributors seeking finished pharmaceutical products across oral and injectable dosage forms. For suppliers, the company is relevant to pharmaceutical ingredients, excipients, packaging and production-support requirements.
Constraints, risk & compliance
Key risks and constraints
The company’s manufacturing scope spans several dosage forms, making continuity of pharmaceutical ingredients, excipients, packaging and quality-controlled production inputs material to operations. Product-level demand and manufacturing performance can also vary by therapeutic mix.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Chemidarou Industrial Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Chemidarou Industrial Company manufacture?
Chemidarou manufactures finished pharmaceutical products in tablet, capsule, injectable ampoule, drop and oral-suspension forms.
Where is Chemidarou Industrial Company based?
The company is based in Tehran, Tehran Province, Iran.
Is Chemidarou listed on the Tehran Stock Exchange?
Yes. Chemidarou has been listed on the Tehran Stock Exchange since 1991 under ticker دکیمی (DKIMI).
When was Chemidarou founded?
The company was founded in 1965 and later adopted the Chemidarou Industrial Company name in 1980/81.